Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Biological Chemistry
|
September 24, 2013
Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis
Harshil Dhruv, Joseph C Loftus, Pooja Narang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2025
Overcoming CK1α liability in the discovery of a series of isoIndolinone Glutarimides as selective IKZF2 molecular glue degraders
Xuqing Zhang, Qiaolin Deng, Harshil Dhruv, et al.
Neuro-Oncology
|
December 10, 2016
Integrated genomic analysis of survival outliers in glioblastoma
Sen Peng, Harshil Dhruv, Brock Armstrong, et al.
International Journal of Cancer
|
March 31, 2011
MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration
Shilpi Arora, Aarati R Ranade, Nhan L Tran, et al.
Journal of Medicinal Chemistry
|
August 22, 2025
Discovery of a Novel Series of <i>iso</i>-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders
Xuqing Zhang, Harshil Dhruv, Qiaolin Deng, et al.
Nature Communications
|
May 1, 2025
Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy
Zhixiang Chen, Harshil Dhruv, Xuqing Zhang, et al.
Neuro-Oncology Advances
|
August 4, 2020
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression
Mylan R Blomquist, Shannon Fortin Ensign, Fulvio D'Angelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Biological Chemistry
|
September 24, 2013
Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis
Harshil Dhruv, Joseph C Loftus, Pooja Narang, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 2025
Overcoming CK1α liability in the discovery of a series of isoIndolinone Glutarimides as selective IKZF2 molecular glue degraders
Xuqing Zhang, Qiaolin Deng, Harshil Dhruv, et al.
Neuro-Oncology
|
December 10, 2016
Integrated genomic analysis of survival outliers in glioblastoma
Sen Peng, Harshil Dhruv, Brock Armstrong, et al.
International Journal of Cancer
|
March 31, 2011
MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration
Shilpi Arora, Aarati R Ranade, Nhan L Tran, et al.
Journal of Medicinal Chemistry
|
August 22, 2025
Discovery of a Novel Series of <i>iso</i>-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders
Xuqing Zhang, Harshil Dhruv, Qiaolin Deng, et al.
Nature Communications
|
May 1, 2025
Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy
Zhixiang Chen, Harshil Dhruv, Xuqing Zhang, et al.
Neuro-Oncology Advances
|
August 4, 2020
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression
Mylan R Blomquist, Shannon Fortin Ensign, Fulvio D'Angelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
Page
of 2